ILK and neoplasm: The DNA component of NETs was found to act as a chemotactic factor to attract tumor cells through an extracellular DNA-sensor, CCDC25, expressed on tumor cells which subsequently activated the integrin-linked kinase (ILK)-β-parvin pathway to enhance cell motility [109].